Meet the Minds
Behind Decode Health

Decode Health is a Nashville-based analytics company offering a health management analytics solution that can predict and monitor chronic diseases including multiple sclerosis, Crohn’s disease and chronic kidney disease. Relying on deep disease knowledge and expert data modeling techniques, the platform identifies patients heading towards a diagnosis earlier than conventional approaches, spotlights potential misdiagnosis and identifies trends that are predictive of high-cost adverse events. The patent-pending technology provides insights that enable proactive patient care and improve patient outcomes.

In any population, there is undiagnosed, misdiagnosed, or uncontrolled chronic disease that represents a guaranteed risk to health plans and self-insured employers. Accurately detecting and effectively monitoring chronic conditions, including autoimmune disease, requires expert disease knowledge combined with the analytical speed, scale and efficiency of machine learning. Decode Health is the only company that has both. Decode’s solution predicts, detects and monitors chronic disease and helps care managers improve outcomes by identifying patients earlier which leads to better outcomes and lower costs.

Interested in Joining Our Team?


Chase Spurlock, PhD

Chief Executive Officer

Julia Polk

Chief Strategy Officer 


Amy Gleason

US Digital Service
The White House

Don Hardison

President & CEO
Biotheranostics, Inc.

Damian Mingle

Chief Data Scientist
Switchpoint Ventures

Alan Spiro, MD, MBA

Healthcare Strategy Leader

David Coppeans

Sr. Vice President of Strategic Operations, Amedisys